论文部分内容阅读
市场价值不同于道德或者伦理价值,当我们致力于研究国家药物政策时,应当清醒地意识到,尽管从总体目标来看国家药物政策本身体现了社会认可的公平性以及社会伦理的基本观念,但是,其实际的制订与实施很可能是一次又一次的利益博弈,不同的利益群体所认可的价值存在着根本性的差异。作为一种制度安排,国家药物政策的制订及其实施必定涉及到经济利益。制药企业是经济利益最主要的关联方,对于制药企业而言,国家药物政策中的经济目标和可能引致的经济后果是其所唯一关注的,并在国家药物政策从制订到实施的不同层级中寻求最大化其经济利益的可能。
Market value differs from ethical or ethical values and when we devote ourselves to the study of national drug policies, we should be clearly aware that although the national drug policy itself, on the overall goal, reflects the fairness of social acceptance and the basic concepts of social ethics, Its actual formulation and implementation is likely to be a game of interests again and again. There are fundamental differences in the values recognized by different interest groups. As a system arrangement, the formulation and implementation of the national drug policy must involve economic interests. Pharmaceutical companies are the most important related parties to economic interests. For the pharmaceutical enterprises, the economic goals and possible economic consequences of the national drug policy are the only concerns of the pharmaceutical companies. At the different levels from formulation to implementation of the national drug policy, Seeking the possibility of maximizing their economic interests.